UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lung cancer is also a hereditary disease

European respiratory review, 2021-12, Vol.30 (162), p.210045

2021

Volltextzugriff (PDF)

Sarcomatoid lung carcinomas show high levels of Programmed Death Ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

Lung cancer (Amsterdam, Netherlands), 2016-08, Vol.98, p.51-58

2016

Volltextzugriff (PDF)

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

European respiratory review, 2019-09, Vol.28 (153), p.190058

2019

Volltextzugriff (PDF)

Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France

Emerging infectious diseases, 2024-11, Vol.30 (11), p.2445-2447

2024

Volltextzugriff (PDF)

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.e224-e226

2019

Volltextzugriff (PDF)

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports

Frontiers in oncology, 2023-06, Vol.13, p.1182558-5

2023

Volltextzugriff (PDF)

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Cardiovascular and interventional radiology, 2019-12, Vol.42 (12), p.1806-1809

2019

Volltextzugriff (PDF)

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.276-281

2014

Volltextzugriff (PDF)

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

Oncotarget, 2017-06, Vol.8 (26), p.42428-42437

2017

Volltextzugriff (PDF)

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

Pharmaceutics, 2022-09, Vol.14 (9), p.1844

2022

Volltextzugriff (PDF)

Prospective screening for ALK : Clinical features and outcome according to ALK status

European journal of cancer (1990), 2014-05, Vol.50 (7), p.1239-1246

2014

Volltextzugriff (PDF)

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells

Frontiers in immunology, 2022-12, Vol.13, p.1082084-1082084

2022

Volltextzugriff (PDF)

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

ERJ open research, 2018-04, Vol.4 (2), p.120-2017

2018

Volltextzugriff (PDF)

Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.1061-1063

2012

Volltextzugriff (PDF)

Emerging cancer risks in BRCA2 pathogenic germline variant carriers

European journal of human genetics : EJHG, 2023-12, Vol.31 (12), p.1355-1356

2023

Volltextzugriff (PDF)

Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?

Journal of clinical oncology, 2022-08, Vol.40 (22), p.JCO2200488-2508

2022

Volltextzugriff (PDF)

Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report

Clinical lung cancer, 2022-12, Vol.23 (8), p.e568-e572

2022

Volltextzugriff (PDF)

Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.e95-e96

2019

Volltextzugriff (PDF)

Multimodal machine learning model prediction of “individual” response to immunotherapy in 1L stage IV NSCLC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21151-e21151

2022

Volltextzugriff (PDF)

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

The lancet respiratory medicine, 2020-07, Vol.8 (7), p.709-716

2020

Volltextzugriff (PDF)

Invited editorial: Q and A on hereditary lung cancer

Respiratory medicine and research, 2022-05, Vol.81, p.100881-100881, Article 100881

2022

Volltextzugriff (PDF)

Bevacizumab in combination with chemotherapy for treating patients with advanced RET+ non-small cell lung cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8647-8647

2024

Volltextzugriff (PDF)

Characterization of lung cancers in patients with BRCA germline variants: A multicenter series

Lung cancer (Amsterdam, Netherlands), 2022-11, Vol.173, p.67-70

2022

Volltextzugriff (PDF)

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1962-1967

2018

Volltextzugriff (PDF)

Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9082-9082

2022

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(55)
Französisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(27)
Life Sciences
(25)
Oncology
(21)
Respiratory System
(17)
Cancer
(13)
Female
(12)
Male
(12)
Lung Neoplasms - Drug Therapy
(9)
Lung Neoplasms - Genetics
(9)
Lung Neoplasms - Pathology
(9)
Lung Cancer
(8)
Middle Aged
(8)
Mutation
(8)
Adult
(7)
Non-Small Cell Lung Cancer
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(6)
Human Health And Pathology
(6)
Protein Kinase Inhibitors - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lung cancer is also a hereditary disease

Sarcomatoid lung carcinomas show high levels of Programmed Death Ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

Prospective screening for ALK : Clinical features and outcome according to ALK status

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient

Emerging cancer risks in BRCA2 pathogenic germline variant carriers

Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?

Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report

Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib

Multimodal machine learning model prediction of “individual” response to immunotherapy in 1L stage IV NSCLC

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

Invited editorial: Q and A on hereditary lung cancer

Bevacizumab in combination with chemotherapy for treating patients with advanced RET+ non-small cell lung cancer

Characterization of lung cancers in patients with BRCA germline variants: A multicenter series

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort

Suchergebnisse filtern